InnoCare Pharma Limited

SEHK:9969 Rapport sur les actions

Capitalisation boursière : HK$9.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

InnoCare Pharma Bilan de santé

Santé financière contrôle des critères 5/6

InnoCare Pharma has a total shareholder equity of CN¥7.1B and total debt of CN¥343.3M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are CN¥9.8B and CN¥2.7B respectively.

Informations clés

4.9%

Ratio d'endettement

CN¥343.30m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideCN¥8.20b
Fonds propresCN¥7.05b
Total du passifCN¥2.71b
Total des actifsCN¥9.77b

Mises à jour récentes de la santé financière

Recent updates

Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Jun 21
Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Some Analysts Just Cut Their InnoCare Pharma Limited (HKG:9969) Estimates

Apr 02
Some Analysts Just Cut Their InnoCare Pharma Limited (HKG:9969) Estimates

Is InnoCare Pharma (HKG:9969) Weighed On By Its Debt Load?

Feb 14
Is InnoCare Pharma (HKG:9969) Weighed On By Its Debt Load?

Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Oct 06
Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Is InnoCare Pharma (HKG:9969) Using Too Much Debt?

May 11
Is InnoCare Pharma (HKG:9969) Using Too Much Debt?

Is There An Opportunity With InnoCare Pharma Limited's (HKG:9969) 36% Undervaluation?

Apr 11
Is There An Opportunity With InnoCare Pharma Limited's (HKG:9969) 36% Undervaluation?

Is InnoCare Pharma (HKG:9969) A Risky Investment?

Jan 25
Is InnoCare Pharma (HKG:9969) A Risky Investment?

Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

Sep 05
Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

InnoCare Pharma (HKG:9969) Is Using Debt Safely

Apr 30
InnoCare Pharma (HKG:9969) Is Using Debt Safely

InnoCare Pharma Limited's (HKG:9969) Intrinsic Value Is Potentially 100% Above Its Share Price

Nov 13
InnoCare Pharma Limited's (HKG:9969) Intrinsic Value Is Potentially 100% Above Its Share Price

Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

Oct 18
Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

Analyse de la situation financière

Passif à court terme: 9969's short term assets (CN¥8.6B) exceed its short term liabilities (CN¥2.1B).

Passif à long terme: Les actifs à court terme de 9969 ( CN¥8.6B ) dépassent ses passifs à long terme ( CN¥656.9M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 9969 has more cash than its total debt.

Réduire la dette: 9969 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: 9969 has sufficient cash runway for more than 3 years based on its current free cash flow.

Prévisions de trésorerie: Insufficient data to determine if 9969 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Découvrir des entreprises saines